Article

Rheumatology Network's Top 5: June 25, 2022

Author(s):

Lana Pine

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 25, 2022.

Gout Flares Predicted by Monosodium Urate Deposits, Subclinical Inflammation

Differences among baseline clinical and laboratory characteristics between cases and controls were observed in those with a presence of subcutaneous tophi and higher serum urate levels.

Plasma Levels of Glycoprotein Acetyls Linked to Incident Gout

Investigators identified novel biomarkers of incident gout and replicated novel metabolomic biomarkers of gout, including plasma levels of glycoprotein acetyls.

ACR, AAHKS Updates Guidelines for Patients with Rheumatic Disease Undergoing Knee, Hip Surgery

The American College of Rheumatology (ACR)/American Association of Hip and Knee Surgeons (AAHKS) has published guidance regarding perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty.

4 Ways Rheumatology Practices can Navigate Supply Chain Disruptions

Community rheumatology practices are finding it increasingly difficult to source vital therapies and supplies to care for patients.

Rheumatology Network's Rheumatoid Arthritis Quiz Roundup

Test your knowledge of the treatment and management of rheumatoid arthritis with our latest RA quizzes.

Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Abdul Abdellatif, MD: Early Osteopenia Interventions Needed for Patients With Kidney Disease and Gout
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Related Content
Megan Clowse, MD, MPH: Improving Disease and Reducing Corticosteroids in SLE With DZP
November 21st 2024

Megan Clowse, MD, MPH: Improving Disease and Reducing Corticosteroids in SLE With DZP

Victoria Johnson
Emerging Agents in the Treatment of Gout
December 19th 2023

Emerging Agents in the Treatment of Gout

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Gordan Lam, MD
Philip Conaghan, MBBS, PhD, director, National Institute for Health & Care Research Leeds Biomedical Research Centre, and professor, Musculoskeletal Medicine, University of Leeds
November 20th 2024

LEVI-04 Improved Outcomes in Knee Osteoarthritis Compared With Placebo

Victoria Johnson
Emerging Agents in the Treatment of Rheumatic Diseases
October 2nd 2023

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR Andrew Sharobeem, DO, FACR Philip J. Mease, MD
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
November 19th 2024

Vagus Nerve Stimulation Yields Responses in Refractory Rheumatoid Arthritis

Victoria Johnson
Hermine Brunner, MD, MDc, MBA, Director, Division of Rheumatology, and professor, Department of Pediatrics, Cincinnati Children’s
November 18th 2024

Tofacitinib Not Superior to Placebo in Systemic Juvenile Arthritis Double-Blind Trial

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.